Page last updated: 2024-10-29

ketorolac and Cataract

ketorolac has been researched along with Cataract in 13 studies

Ketorolac: A pyrrolizine carboxylic acid derivative structurally related to INDOMETHACIN. It is an NSAID and is used principally for its analgesic activity. (From Martindale The Extra Pharmacopoeia, 31st ed)
ketorolac : A racemate comprising equimolar amounts of (R)-(+)- and (S)-(-)-5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid. While only the (S)-(-) enantiomer is a COX1 and COX2 inhibitor, the (R)-(+) enantiomer exhibits potent analgesic activity. A non-steroidal anti-inflammatory drug, ketorolac is mainly used (generally as the tromethamine salt) for its potent analgesic properties in the short-term management of post-operative pain, and in eye drops to relieve the ocular itching associated with seasonal allergic conjunctivitis. It was withdrawn from the market in many countries in 1993 following association with haemorrhage and renal failure.
5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid : A member of the class of pyrrolizines that is 2,3-dihydro-1H-pyrrolizine which is substituted at positions 1 and 5 by carboxy and benzoyl groups, respectively.

Cataract: Partial or complete opacity on or in the lens or capsule of one or both eyes, impairing vision or causing blindness. The many kinds of cataract are classified by their morphology (size, shape, location) or etiology (cause and time of occurrence). (Dorland, 27th ed)

Research Excerpts

ExcerptRelevanceReference
"To compare pain and the need for the opioid fentanyl use associated with the administration of phenylephrine 1."9.51Pain control and reduction of opioid use associated with intracameral phenylephrine1.0%-ketorolac 0.3% administered during cataract surgery. ( Donnenfeld, ED; Mychajlyszyn, A; Mychajlyszyn, D; Stein, R, 2022)
"Participants scheduled for cataract removal were randomized to 1 of 5 anti-inflammatory prophylactic regimens: eye drops with a combination of prednisolone, 1%, and ketorolac tromethamine, 0."9.41Prednisolone and Ketorolac vs Ketorolac Monotherapy or Sub-Tenon Prophylaxis for Macular Thickening in Cataract Surgery: A Randomized Clinical Trial. ( Erichsen, JH; Forman, JL; Forslund Jacobsen, M; Holm, LM; Kessel, L, 2021)
"A total 91 subjects scheduled to undergo cataract operation were randomized into three groups: Group 1, pre/postoperative bromfenac 0."9.20The Effects of Two Non-Steroidal Anti-Inflammatory Drugs, Bromfenac 0.1% and Ketorolac 0.45%, on Cataract Surgery. ( Chung, BH; Jung, JW; Kim, EK; Kim, TI; Seo, KY, 2015)
"To assess the effectiveness of intracameral phenylephrine-ketorolac during cataract surgery compared with postoperative topical steroids in reducing the incidence of postoperative clinical cystoid macular edema (CME) confirmed via optical coherence tomography (OCT), breakthrough iritis, pain, and photophobia."7.96Effect of intracameral phenylephrine 1.0%-ketorolac 0.3% on postoperative cystoid macular edema, iritis, pain, and photophobia after cataract surgery. ( Bedi, R; Visco, DM, 2020)
"3% was safe for use in children and maintained mydriasis during cataract surgery."6.94Safety and efficacy data supporting U.S. FDA approval of intracameral phenylephrine and ketorolac 1.0%/0.3% for pediatric cataract surgery: clinical safety and pupil and pain management. ( Plager, DA; Trivedi, RH; Wilson, ME, 2020)
" On-label dosing of ketorolac (BID), bromfenac (BID), and nepafenac (TID) was instructed for 1 day prior to surgery."6.76A randomized comparison of to-aqueous penetration of ketorolac 0.45%, bromfenac 0.09% and nepafenac 0.1% in cataract patients undergoing phacoemulsification. ( Bucci, FA; Waterbury, LD, 2011)
"To compare pain and the need for the opioid fentanyl use associated with the administration of phenylephrine 1."5.51Pain control and reduction of opioid use associated with intracameral phenylephrine1.0%-ketorolac 0.3% administered during cataract surgery. ( Donnenfeld, ED; Mychajlyszyn, A; Mychajlyszyn, D; Stein, R, 2022)
"Participants scheduled for cataract removal were randomized to 1 of 5 anti-inflammatory prophylactic regimens: eye drops with a combination of prednisolone, 1%, and ketorolac tromethamine, 0."5.41Prednisolone and Ketorolac vs Ketorolac Monotherapy or Sub-Tenon Prophylaxis for Macular Thickening in Cataract Surgery: A Randomized Clinical Trial. ( Erichsen, JH; Forman, JL; Forslund Jacobsen, M; Holm, LM; Kessel, L, 2021)
"A total 91 subjects scheduled to undergo cataract operation were randomized into three groups: Group 1, pre/postoperative bromfenac 0."5.20The Effects of Two Non-Steroidal Anti-Inflammatory Drugs, Bromfenac 0.1% and Ketorolac 0.45%, on Cataract Surgery. ( Chung, BH; Jung, JW; Kim, EK; Kim, TI; Seo, KY, 2015)
"This study did not demonstrate a difference in the ability of diclofenac or ketorolac ophthalmic solutions to prevent PCO following cataract extraction and implantation of an intraocular lens."5.09Incidence of postoperative posterior capsular opacification following treatment with diclofenac 0.1% and ketorolac 0.5% ophthalmic solutions: 3-year randomized, double-masked, prospective clinical investigation. ( Dolan, BJ; Flach, AJ, 2000)
"Topical NSAIDs were found to be more effective in controlling CME, pain, iritis, and photophobia after cataract surgery compared with the intracanalicular dexamethasone insert in the presence of intracameral phenylephrine/ketorolac."4.31Comparison of postcataract surgery anti-inflammatory regimens on the incidence of cystoid macular edema, iritis, pain, and photophobia. ( Visco, DM, 2023)
"To assess the effectiveness of intracameral phenylephrine-ketorolac during cataract surgery compared with postoperative topical steroids in reducing the incidence of postoperative clinical cystoid macular edema (CME) confirmed via optical coherence tomography (OCT), breakthrough iritis, pain, and photophobia."3.96Effect of intracameral phenylephrine 1.0%-ketorolac 0.3% on postoperative cystoid macular edema, iritis, pain, and photophobia after cataract surgery. ( Bedi, R; Visco, DM, 2020)
"We report the antiinflammatory effect and efficacy of preoperative treatment with ketorolac in a patient with rheumatoid arthritis having phacoemulsification."3.71Antiinflammatory effect of preoperative ketorolac in phacoemulsification. ( Caronia, RM; Donnenfeld, ED; Perry, HD, 2002)
"3% was safe for use in children and maintained mydriasis during cataract surgery."2.94Safety and efficacy data supporting U.S. FDA approval of intracameral phenylephrine and ketorolac 1.0%/0.3% for pediatric cataract surgery: clinical safety and pupil and pain management. ( Plager, DA; Trivedi, RH; Wilson, ME, 2020)
" On-label dosing of ketorolac (BID), bromfenac (BID), and nepafenac (TID) was instructed for 1 day prior to surgery."2.76A randomized comparison of to-aqueous penetration of ketorolac 0.45%, bromfenac 0.09% and nepafenac 0.1% in cataract patients undergoing phacoemulsification. ( Bucci, FA; Waterbury, LD, 2011)

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (15.38)29.6817
2010's5 (38.46)24.3611
2020's6 (46.15)2.80

Authors

AuthorsStudies
Donnenfeld, ED2
Mychajlyszyn, D1
Mychajlyszyn, A1
Stein, R1
Visco, DM2
Wingert, AM2
Liu, SH2
Lin, JC2
Sridhar, J2
Wilson, ME1
Trivedi, RH1
Plager, DA1
Bedi, R1
Erichsen, JH1
Holm, LM1
Forslund Jacobsen, M1
Forman, JL1
Kessel, L1
Mamalis, N1
Sullivan-Mackenna, D1
Roberts, H1
O'Brart, D1
Walter, KA1
Jung, JW1
Chung, BH1
Kim, EK1
Seo, KY1
Kim, TI1
Bucci, FA1
Waterbury, LD1
Caronia, RM1
Perry, HD1
Flach, AJ1
Dolan, BJ1

Clinical Trials (3)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Randomized, Double-Masked, Parallel-Group, Phenylephrine-Controlled Study of the Effect of OMS302 Added to Standard Irrigation Solution on Intraoperative Pupil Diameter and Acute Postoperative Pain in Children Ages Birth Through Three Years Undergoing U[NCT02132312]Phase 378 participants (Actual)Interventional2014-07-31Completed
Effect of Drop-less Surgery Compared to Topical NSAID Alone and Combination of Steroid and NSAID on Central Macular Thickness After Cataract Surgery, a Randomized Controlled Trial[NCT03383328]Phase 4470 participants (Actual)Interventional2018-02-01Completed
The Effect of Preoperative Topical Ketorolac 0.45% on Aqueous Cytokine Levels and Macular Thickness in Diabetic and Non Diabetic Patients Undergoing Cataract Surgery[NCT02646072]Phase 480 participants (Actual)Interventional2014-08-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Trial Outcomes

Acute Postoperative Pain

"Mean AUC Analysis of Postoperative pain as measured using the Alder Hey Triage Pain Score at 3, 6, 9, and 24 hours after surgery. The primary analysis of Alder Hey Triage Pain Score was similar to the primary analysis of the change in pupil diameter using AUC. The Alder Hey Triage Pain Score identifies five categories of observations: voice/cry, facial expression, posture, movement, and color. Each of these has a possible score of 0, 1, or 2, resulting in a total score ranging between 0 and 10. A total score of zero means the subject experienced no pain, as the 5 categories added up totals zero. A total score of 10 means the subject experienced a lot of pain and is the worst possible outcome, as the 5 categories added up totals 10.~Parent responses in a diary with a score of 0, 1, or 2.~Cry or voice, 0=no compliant/cry, 1=Consolable, 2=Inconsolable~Facial Expression, 0=Normal, 1=Short grimace <50% of time, 2=Long grimace >50% of time~Posture, 0=Normal, 1=Touching/rub" (NCT02132312)
Timeframe: 24 hours

Interventionscore*hours (Mean)
OMS3020.44
Phenylephrine HCl0.65

Intraoperative Pupil Diameter

Mean Area-under-the-Curve (AUC) Analysis of Change From Baseline in Pupil Diameter (mm/min) During Surgery Excluding Subjects with In-evaluable Videos. (NCT02132312)
Timeframe: From surgery baseline (pre-incision) through surgery end (time of cortical clean-up/wound closure), the mean time of surgery duration is 35.46 minutes with a standard deviation of 19.98.

Interventionmillimeters*minutes (Mean)
OMS3020.14
Phenylephrine HCl0.20

Safety as Measured by Treatment-emergent Adverse Events, the Number of Affected Patients/at Risk (%) and the Number of Events.

Safety as assessed by the incidence of adverse events and serious adverse events up until the last visit at Day 90. (NCT02132312)
Timeframe: 90 days

InterventionParticipants (Count of Participants)
OMS30215
Phenylephrine HCl18

Reviews

1 review available for ketorolac and Cataract

ArticleYear
Non-steroidal anti-inflammatory agents for treating cystoid macular edema following cataract surgery.
    The Cochrane database of systematic reviews, 2022, 12-15, Volume: 12

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Cataract; Diclofenac; Female; Humans; Ketorolac; Macu

2022
Non-steroidal anti-inflammatory agents for treating cystoid macular edema following cataract surgery.
    The Cochrane database of systematic reviews, 2022, 12-15, Volume: 12

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Cataract; Diclofenac; Female; Humans; Ketorolac; Macu

2022
Non-steroidal anti-inflammatory agents for treating cystoid macular edema following cataract surgery.
    The Cochrane database of systematic reviews, 2022, 12-15, Volume: 12

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Cataract; Diclofenac; Female; Humans; Ketorolac; Macu

2022
Non-steroidal anti-inflammatory agents for treating cystoid macular edema following cataract surgery.
    The Cochrane database of systematic reviews, 2022, 12-15, Volume: 12

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Cataract; Diclofenac; Female; Humans; Ketorolac; Macu

2022

Trials

6 trials available for ketorolac and Cataract

ArticleYear
Pain control and reduction of opioid use associated with intracameral phenylephrine1.0%-ketorolac 0.3% administered during cataract surgery.
    Journal of cataract and refractive surgery, 2022, 07-01, Volume: 48, Issue:7

    Topics: Analgesics, Opioid; Cataract; Double-Blind Method; Epinephrine; Fentanyl; Humans; Ketorolac; Pain; P

2022
Safety and efficacy data supporting U.S. FDA approval of intracameral phenylephrine and ketorolac 1.0%/0.3% for pediatric cataract surgery: clinical safety and pupil and pain management.
    Journal of cataract and refractive surgery, 2020, Volume: 46, Issue:6

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Cataract; Child; Child, Preschool; Double-Blind Method; Hum

2020
Prednisolone and Ketorolac vs Ketorolac Monotherapy or Sub-Tenon Prophylaxis for Macular Thickening in Cataract Surgery: A Randomized Clinical Trial.
    JAMA ophthalmology, 2021, Oct-01, Volume: 139, Issue:10

    Topics: Aged; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Cataract; Cataract Extracti

2021
The Effects of Two Non-Steroidal Anti-Inflammatory Drugs, Bromfenac 0.1% and Ketorolac 0.45%, on Cataract Surgery.
    Yonsei medical journal, 2015, Volume: 56, Issue:6

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Benzophenones; Bromobenzenes; Cataract; Cataract Extr

2015
A randomized comparison of to-aqueous penetration of ketorolac 0.45%, bromfenac 0.09% and nepafenac 0.1% in cataract patients undergoing phacoemulsification.
    Current medical research and opinion, 2011, Volume: 27, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Benzeneacetamides; Benzophe

2011
Incidence of postoperative posterior capsular opacification following treatment with diclofenac 0.1% and ketorolac 0.5% ophthalmic solutions: 3-year randomized, double-masked, prospective clinical investigation.
    Transactions of the American Ophthalmological Society, 2000, Volume: 98

    Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Cataract; Cataract Extraction; Chi

2000

Other Studies

6 other studies available for ketorolac and Cataract

ArticleYear
Comparison of postcataract surgery anti-inflammatory regimens on the incidence of cystoid macular edema, iritis, pain, and photophobia.
    Journal of cataract and refractive surgery, 2023, 01-01, Volume: 49, Issue:1

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Cataract; Dexamethasone; Humans; Incidence; Iritis; Ketorol

2023
Effect of intracameral phenylephrine 1.0%-ketorolac 0.3% on postoperative cystoid macular edema, iritis, pain, and photophobia after cataract surgery.
    Journal of cataract and refractive surgery, 2020, Volume: 46, Issue:6

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Cataract; Cataract Extraction; Cohort Studies; Humans; Irit

2020
Importance of pupil dilation for cataract surgery.
    Journal of cataract and refractive surgery, 2017, Volume: 43, Issue:5

    Topics: Cataract; Cataract Extraction; Dilatation; Humans; Ketorolac; Mydriatics; Pain, Postoperative; Pheny

2017
Reduction in surgical time and iris manipulation using continuous intracameral irrigation of phenylephrine and ketorolac to prevent miosis in FLACS.
    Journal of cataract and refractive surgery, 2019, Volume: 45, Issue:7

    Topics: Cataract; Humans; Iris; Ketorolac; Miosis; Operative Time; Phenylephrine

2019
Reply.
    Journal of cataract and refractive surgery, 2019, Volume: 45, Issue:7

    Topics: Cataract; Humans; Iris; Ketorolac; Miosis; Operative Time; Phenylephrine

2019
Antiinflammatory effect of preoperative ketorolac in phacoemulsification.
    Journal of cataract and refractive surgery, 2002, Volume: 28, Issue:10

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Rheumatoid; Cataract; Drug Therapy, Combin

2002